Lefevre Pharma SRL
3.0 FTEThe score of Lefevre Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +29 % Total assets +82 % Headcount (avg FTE) +36 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lefevre Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jun 2026
- Year ended 31 Dec 2024filed on 05 Jun 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 08 Aug 2023
- Year ended 31 Dec 2021filed on 31 Mar 2022
Lefevre Pharma's financial analysis
- Solvency18.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lefevre Pharma
Lefevre Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0831.780.443
- VAT number
- BE0831780443
- Peppol
- Registered · 0208:0831780443 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Dec 2010
- Registered office
- 6220 Fleurus
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 03 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lefevre Pharma (SRL) has been based in Fleurus since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 57,478 € and equity of 286,391 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.8%, below the median of its sector (41.5%).
Companies similar to Lefevre Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Verset Retail sale of pharmaceutical products Les Bons Villers · balance sheet €1.53m
- Apotheek Nieuwenhove Retail sale of pharmaceutical products Oostkamp · balance sheet €1.53m
- Scentia Retail sale of pharmaceutical products Mont-Saint-Guibert · balance sheet €1.54m
- Pharmacies Biot-Gyselinck Retail sale of pharmaceutical products Faimes · balance sheet €1.51m
- Sophade Retail sale of pharmaceutical products Wavre · balance sheet €1.54m
- Apoteek Toelen Retail sale of pharmaceutical products Sint-Pieters-Leeuw · balance sheet €1.51m
- Pharmart Retail sale of pharmaceutical products Etterbeek · balance sheet €1.51m
- Binche Pharma Retail sale of pharmaceutical products Binche · balance sheet €1.51m
Frequently asked questions about Lefevre Pharma
What is the revenue of Lefevre Pharma?
Lefevre Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lefevre Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0831780443 for Lefevre Pharma, if the company is VAT-registered. Its company number (CBE) is 0831.780.443.
Where is the registered office of Lefevre Pharma?
According to the CBE register, the registered office of Lefevre Pharma is in 6220 Fleurus.
What is the equity of Lefevre Pharma?
At the close of the 2025 financial year, the equity of Lefevre Pharma amounts to 286,391 €, a solvency of 18.8% of total assets.
How many people work at Lefevre Pharma?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Lefevre Pharma?
The register lists 1 active mandates at Lefevre Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lefevre Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →